Ironwood Pharmaceuticals (IRWD) Debt to Equity (2016 - 2025)
Historic Debt to Equity for Ironwood Pharmaceuticals (IRWD) over the last 13 years, with Q3 2025 value amounting to -$2.21.
- Ironwood Pharmaceuticals' Debt to Equity fell 7222.39% to -$2.21 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.21, marking a year-over-year decrease of 7222.39%. This contributed to the annual value of -$1.28 for FY2024, which is 1143.35% up from last year.
- According to the latest figures from Q3 2025, Ironwood Pharmaceuticals' Debt to Equity is -$2.21, which was down 7222.39% from -$1.9 recorded in Q2 2025.
- Ironwood Pharmaceuticals' Debt to Equity's 5-year high stood at $0.23 during Q1 2022, with a 5-year trough of -$2.21 in Q3 2025.
- Over the past 5 years, Ironwood Pharmaceuticals' median Debt to Equity value was -$1.3 (recorded in 2024), while the average stood at -$1.04.
- Per our database at Business Quant, Ironwood Pharmaceuticals' Debt to Equity surged by 2353.46% in 2024 and then plummeted by 7222.39% in 2025.
- Quarter analysis of 5 years shows Ironwood Pharmaceuticals' Debt to Equity stood at $0.19 in 2021, then rose by 20.75% to $0.23 in 2022, then plummeted by 719.46% to -$1.44 in 2023, then rose by 11.43% to -$1.28 in 2024, then crashed by 73.19% to -$2.21 in 2025.
- Its last three reported values are -$2.21 in Q3 2025, -$1.9 for Q2 2025, and -$1.15 during Q1 2025.